Contact Person : Kris Waterman; Last Date for the submission of abstract : Not Available ; Description : This conference will highlight the cutting edge in vitro and in vivo preclinical models that allow researchers to more effectively evaluate novel cancer therapeutics, as well as identify predictive biomarkers in early stages of drug development.